CapsoVision
Update in progressCV (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
CapsoVision, Inc. is a medical technology company that develops and markets endoscopic imaging for the gastrointestinal tract. Its CapsoCam Plus capsule enables visualization of the small bowel mucosa in adults and children aged 2+, while CapsoCam Colon images the colon to detect and measure polyps. The company also offers CapsoCloud, CapsoView, CapsoAccess, CapsoRetrieve, and capsule video reading services. It serves GI clinics, hospitals, and distributors. Based in Saratoga, CA; founded 2005. Name change to CapsoVision, Inc. in 2016.
Company score
- Sentiment
- 0.18
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.12
- Governance
- 0.10
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.12
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!